XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 2,871,756 $ 5,872,767
Advances and deposits on clinical programs and other current assets 2,220,200 2,136,192
Total current assets 5,091,956 8,008,959
Property and equipment (at cost, less accumulated depreciation and amortization) 734,243 541,272
Other assets:    
Operating lease right-of-use assets, net 985,887 1,117,133
Deposits and other assets 50,000 50,000
Total other assets 1,035,887 1,167,133
Total assets 6,862,086 9,717,364
Current liabilities:    
Accounts payable – trade 1,858,602 1,300,026
Other accrued liabilities 3,543,407 3,033,747
Operating lease liability - current portion 394,878 452,358
Total current liabilities 5,796,887 4,786,131
Operating lease liability - non-current portion 613,171 686,935
Total liabilities 6,410,058 5,473,066
Commitments and contingencies
Stockholders’ equity:    
Preferred stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at March 31, 2025 and December 31, 2024
Common stock - $0.01 par value (112,500,000 shares authorized; 14,620,754 and 14,500,707 shares issued at March 31, 2025 and December 31, 2024, respectively; and 14,620,732 and 14,500,685 shares outstanding at March 31, 2025 and December 31, 2024, respectively) 146,207 145,007
Additional paid-in capital 411,296,548 410,987,523
Accumulated deficit (410,905,539) (406,803,044)
Total stockholders’ equity before treasury stock 537,216 4,329,486
Treasury stock, at cost (22 shares at March 31, 2025 and December 31, 2024) (85,188) (85,188)
Total stockholders’ equity 452,028 4,244,298
Total liabilities and stockholders’ equity $ 6,862,086 $ 9,717,364